We also tested its treatment efficacies in 2 preclinical models of autoimmune uveitis using our CD6-humanized mice and a humanized model of GVHD using NOD/SCID IL-2 receptor γ–/– (NSG) mice. Here, CD6 is linked to autoimmune uveitis.